Published in Obesity and Diabetes Week, April 12th, 2004
Their novel approach involves bioengineering gut peptides - molecules produced in the human intestine and released in response to feeding - to prolong their duration of action and therefore make them work more effectively.
The research by the internationally recognized Diabetes Research Group at the university's Coleraine campus could lead to the development of new therapies to combat type 2 diabetes.
Findings of the group's research were presented recently to the Diabetes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week